The Possible Role of the Microbiota-Gut-Brain-Axis in Autism Spectrum Disorder
Open accessThe DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Abstract
New research points to a possible link between autism spectrum disorder (ASD) and the gut microbiota as many autistic children have co-occurring gastrointestinal problems. This review focuses on specific alterations of gut microbiota mostly observed in autistic patients. Particularly, the mechanisms through which such alterations may trigger the production of the bacterial metabolites, or leaky gut in autistic people are described. Various altered metabolite levels were observed in the blood and urine of autistic children, many of which were of bacterial origin such as short chain fatty acids (SCFAs), indoles and lipopolysaccharides (LPS). A less integrative gut-blood-barrier is abundant in autistic individuals. This explains the leakage of bacterial metabolites into the patients, triggering new body responses or an altered metabolism. Some other co-occurring symptoms such as mitochondrial dysfunction, oxidative stress in cells, altered tight junctions in the blood-brain barrier and structural changes in the cortex, hippocampus, amygdala and cerebellum were also detected. Moreover, this paper suggests that ASD is associated with an unbalanced gut microbiota (dysbiosis). Although the cause-effect relationship between ASD and gut microbiota is not yet well established, the consumption of specific probiotics may represent a side-effect free tool to re-establish gut homeostasis and promote gut health. The diagnostic and therapeutic value of bacterial-derived compounds as new possible biomarkers, associated with perturbation in the phenylalanine metabolism, as well as potential therapeutic strategies will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Methodical approach of this systematic review due to PRISMA criteria [39].](https://figures.cochat.ai/paper-figures/995f3e7c1bdb4e7fa5d481ab1b14c477/the-possible-role-of-the-microbiota-gut-brain-axis-in-autism-spectrum-disorder-figure-1.jpg)


![Figure 4 Process of Clostridium tetani infection in the gut. Occurrence of the bacterium Clostridium tetani in the GI tract of autistic population could lead to altered behaviour. [43].](https://figures.cochat.ai/paper-figures/43898fd3bd604a37b876bb8b1235dffb/the-possible-role-of-the-microbiota-gut-brain-axis-in-autism-spectrum-disorder-figure-4.jpg)
![Figure 5 Metabolic pathways of tryptophan. The purple pathways show human metabolism of tryptophan and the orange pathways are observed in bacterial degradation. Green surrounded boxes show elevated metabolites and red surrounded boxes show decreased metabolites in the autistic metabolome [101].](https://figures.cochat.ai/paper-figures/cbe7bd9ad387486b9f15801bc57a30b3/the-possible-role-of-the-microbiota-gut-brain-axis-in-autism-spectrum-disorder-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased BBB permeability has been associated with heightened microglial activity and a reduction in astrocyte numbers and functionality [52,76].”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies has shown a significant increase in the prevalence of Clostridium bacteria in ASD patients compared to the general population [8,50,52,96,97,98,99,100,101,102,103,104,105,106,107,108,109].”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A notable decrease in the prevalence of bacteria from the Veillonellaceae and Streptococcaceae families was observed in patients with ASD.”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It was also observed that the abundance of the genus Faecalibacterium, particularly the Faecalibacterium prausnitzii species, should be lower in healthy individuals compared to patients diagnosed with ASD [52,89,101,107,109,113].”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, the presence of Staphylococcus, Coprococcus, Lactococcus, and Flavonifractor may be detected in lower quantities [8,52,107,111,114,115].”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [52]
Experimental — accuracy not yet measured
25 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 2×
“ethodical approach of this systematic review due to PRISMA criteria [39].”
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., Kurzius-Spencer, M., Zahorodny, W., Robinson, C., Rosenberg, et al. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6706a1 · Cited by 6,078
Hsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, S. E., Petrosino, J. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.024 · Cited by 3,283 · cited 8×
“Sci. 2019, 20, 2115 19 of 28 Lactobacillus rhamnosus, Bifidobacterium infantis, Bifidobacterium longus, Lactobacillus helveticus, Lactobacillus reuteri and Lactobacillus paracasei Improvement of GI problems Humans [106] Lactobacillus reuteri - Reversing inflammation caused through lipopolysaccharides - Stimulating the…”
BackgroundInfluentialInteractions between the microbiota, immune and nervous systems in health and disease
Fung, T. C., Olson, C. A., & Hsiao, E. Y. (2017) · Nature Neuroscience · doi:10.1038/nn.4476 · Cited by 1,900
The central nervous system and the gut microbiome
Sharon, G., Sampson, T. R., Geschwind, D. H., & Mazmanian, S. K. (2016) · Cell · doi:10.1016/j.cell.2016.10.027 · Cited by 1,513 · cited 1×
“The microbial composition varies through age, diet, diseases, geography [37,68] and shared environment [34].”
BackgroundGut/brain axis and the microbiota
Mayer, E. A., Tillisch, K., & Gupta, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76304 · Cited by 1,503
Kang, D.-W., Adams, J. B., Gregory, A. C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., McDonough-Means, S., et al. (2017) · Microbiome · doi:10.1186/s40168-016-0225-7 · Cited by 1,391 · cited 13×
“Especially, faecal microbiota transfers significantly ameliorated ASD behavioural symptoms and GI problems in autistic children [79].”
BackgroundMethodInfluentialHow informative is the mouse for human gut microbiota research?
Nguyen, T. L. A., Vieira-Silva, S., Liston, A., & Raes, J. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.017400 · Cited by 1,334
Cited by
Items 101–200 of 427
van Eijndhoven, P., Collard, R. M., Vrijsen, J. N., Geurts, D. E. M., Vásquez, A. A., Schellekens, A., van den Munckhof, E., Brolsma, S. C. A., Duyser, F. A., Bergman, M. A., et al. (2022) · JMIRx Med · doi:10.2196/31269 · Cited by 39
Raghavan, K., Dedeepiya, V. D., Ikewaki, N., Sonoda, T., Iwasaki, M., Preethy, S., & Abraham, S. J. (2022) · BMJ Neurology Open · doi:10.1136/bmjno-2021-000203 · Cited by 35
Fu, S.-C., Lee, C., & Wang, H. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18020667 · Cited by 36
“Recent studies have revealed differences between the gut microbiomes (the genomic profiles of gut microbiota) of ASD patients and healthy individuals, suggesting that ASD is associated with an unbalanced gut microbiota [12].”
BackgroundResultLin, P., Zhang, Q., Sun, J., Li, Q., Li, D., Zhu, M., Fu, X., Zhao, L., Wang, M., Lou, X., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1318637 · Cited by 39
“Altered microbial compositions and imbalances in microbial metabolites have been reported in individuals with ASD, suggesting a potential role for the gut microbiome as a biomarker and therapeutic target for the disorder (119–121).”
BackgroundAlteration of the gut microbiota profile in children with autism spectrum disorder in China
Li, H., Guo, W., Li, S., Sun, B., Li, N., Xie, D., Dong, Z., Luo, D., Chen, W., Fu, W., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1326870 · Cited by 38
“Research has shown that the human gut microbiota plays a crucial role in influencing the brain through a communication pathway, called the gut-brain axis (Fowlie et al., 2018; Iannone et al., 2019; Lacorte et al., 2019; Sharon et al., 2019; Srikantha and Mohajeri, 2019).”
BackgroundŻebrowska-Różańska, P., Łaczmańska, I., & Łaczmański, Ł. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.630052 · Cited by 36
Carter, S., Lin, J. C., Chow, T., Yu, X., Rahman, M. M., Martinez, M. P., Feldman, K., Eckel, S. P., Chen, J., Chen, Z., et al. (2022) · Autism · doi:10.1177/13623613221118430 · Cited by 34
“While differences in the gut microbiota of children have been linked to neurodevelopment and behavior (Srikantha & Mohajeri, 2019), evidence for the influence of gut microbiota on development and treatment of ASD remains equivocal (Tan et al., 2021).”
BackgroundLee, M., Lai, H., Kuo, Y., & Chen, V. C. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12101634 · Cited by 33
“Furthermore, the gut microbiota has also been reported to affect host development and physiology, which is linked to autism and ADHD [12,13].”
BackgroundLin, C.-H., Zeng, T., Lu, C.-W., Li, D.-Y., Liu, Y.-Y., Li, B., Chen, S., & Deng, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1447059 · Cited by 34
“This suggested that GABA/glutamate anomalies may be crucially involved in the pathology of ASD (61, 63).”
BackgroundVaried Composition and Underlying Mechanisms of Gut Microbiome in Neuroinflammation
Farooq, R. K., Alamoudi, W., Alhibshi, A., Rehman, S., Sharma, A. R., & Abdulla, F. A. (2022) · Microorganisms · doi:10.3390/microorganisms10040705 · Cited by 34
Critical role of dysfunctional mitochondria and defective mitophagy in autism spectrum disorders
Wang, Y., Qiu, M.-Y., Liu, Q., Tang, H., & Gu, H. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.12.022 · Cited by 31
The effect of probiotic, prebiotic and gut microbiota on ASD: A review and future perspectives
Şanlıer, N., & Kocabaş, Ş. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1973957 · Cited by 33
“Therefore, gastrointestinal symptoms such as diarrhea, constipation, abdominal pain, bloating, vomiting, reflux, gas, food allergies, and foul-smelling stools are four times more in children with autism (Srikantha and Mohajeri 2019).”
BackgroundExploring sulforaphane as neurotherapeutic: targeting Nrf2-Keap & Nf-Kb pathway crosstalk in ASD
Shah, A., Varma, M., & Bhandari, R. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01224-4 · Cited by 33
“This change in gut microbiota in turn leads to a change in the levels of SCFAs in the bloodstream, which can further bring about damage to Purkinje cells in the cerebellum (Srikantha and Hasan Mohajeri 2019).”
Ugwu, O. P.-C., Okon, M. B., Alum, E. U., Ugwu, C. N., Anyanwu, G. E., Basajja, M., Ogenyi, F. C., Eze, V. H. U., Anyanwu, C. N., Ezeonwumelu, J. O. C., et al. (2025) · Medicine · doi:10.1097/md.0000000000043542 · Cited by 33
“[24] Communication between hosts and intestinal bacteria occurs via the synthesis of a great number of metabolites, including neurotransmitters such as gamma-aminobutyric (GABA), serotonin, dopamine (DA), and noradrenaline, as well as vitamins and SCFAs, almost exclusively within the gut.”
Alkuwaiti, S. H., Skrabulyte-Barbulescu, J., Yassin, L. K., Almazrouei, S., Aldhaheri, D., Alderei, M., BaniYas, S., Alshamsi, S. H., Alnuaimi, A., Saeed, S., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07279-4 · Cited by 32
Changes in the gut microbiota of Nigerian infants within the first year of life
Oyedemi, O. T., Shaw, S., Martin, J. C., Ayeni, F. A., & Scott, K. P. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265123 · Cited by 30
“The abundance of Collinsella aerofaciens and Sutterella, in the exclusively breastfed (EBF) infants is consistent with other studies of breastfed infants [49, 50].”
ResultLu, X., Xue, Z.-Y., Yu, Q., Wei, S., Qiao, Y., Zhang, W., & Lü, H. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.945851 · Cited by 31
Chakraborty, P., Banerjee, D., Majumder, P., & Sarkar, J. (2024) · Medicine in Microecology · doi:10.1016/j.medmic.2024.100104 · Cited by 29
Nitschke, A. S., do Valle, H. A., Vallance, B. A., Bickford, C., Ip, A., Lanphear, N. E., Lanphear, B. P., Weikum, W., Oberlander, T. F., & Hanley, G. E. (2023) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12972 · Cited by 29
Autism spectrum disorder research: knowledge mapping of progress and focus between 2011 and 2022
Jiang, M., Lu, T., Yang, K., Li, X., Zhao, L., Zhang, D., Li, J., & Wang, L. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1096769 · Cited by 33
Gut microbiota of children with autism spectrum disorder and healthy siblings: A comparative study
Abuljadayel, D. A., Alotibi, A., Alqothmi, K., Basingab, F. S., Alhazmi, S., Almuhammadi, A., Alharthi, A., Alyoubi, R. A., & Bahieldin, A. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12719 · Cited by 29
“Certain Bifidobacterium species showed decreased levels in children with autism compared with healthy individuals; bacteria from this species produce γ ‑aminobutyric acid (77), which is closely associated with glutamate metabolism and is a major excitatory neurotransmitter in the brain (78).”
BackgroundJendraszak, M., Gałęcka, M., Kotwicka, M., Regdos, A., Pazgrat-Patan, M., & Andrusiewicz, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-03794-8 · Cited by 27
Boonchooduang, N., Louthrenoo, O., Likhitweerawong, N., Kunasol, C., Thonusin, C., Sriwichaiin, S., Nawara, W., Chattipakorn, N., & Chattipakorn, S. C. (2025) · Scientific Reports · doi:10.1038/s41598-025-87546-y · Cited by 27
James, D. M., Davidson, E. A., Yanes, J. A., Moshiree, B., & Dallman, J. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.662916 · Cited by 26
“Furthermore, the interconnected aspects of the gut-brain-microbiome offer alternative causal explanations and treatment strategies for symptoms traditionally understood to be strictly caused by deficits within the central nervous system (CNS) (Neuhaus et al., 2018; Lefter et al., 2019; Srikantha and Mohajeri, 2019; Ty…”
BackgroundKong, X., Liu, K., Zhuang, P., Tian, R., Liu, S., Clairmont, C. D., Lin, X., Sherman, H. T., Zhu, J., Wang, Y., et al. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09800-9 · Cited by 25
“Lipopolysaccharide (LPS), endotoxin from gram-negative pathogenic bacteria such as Escherichia-Shigella, has been reportedly involved in the development of obesity and autism.[53, 54] Taken together, the microbiome composition data and predictive functional gene analysis indicate that the diversity separation caused b…”
A metaproteomic-based gut microbiota profiling in children affected by autism spectrum disorders
Mortera, S. L., Vernocchi, P., Basadonne, I., Zandonà, A., Chierici, M., Durighello, M., Marzano, V., Gardini, S., Gasbarrini, A., Urbani, A., et al. (2021) · Journal of Proteomics · doi:10.1016/j.jprot.2021.104407 · Cited by 28
Senarathne, U. D., Indika, N.-L. R., Jezela‐Stanek, A., Ciara, E., Frye, R. E., Chen, C., & Stępień, K. M. (2023) · Genes · doi:10.3390/genes14040803 · Cited by 29
“The main dysregulations, including intestinal dysbiosis [5], immune dysfunction, metabolic dysfunction [6], and metal dyshomeostasis [7], have been identified using molecular biomarkers, such as gut microbiome-related metabolites, cytokine profile, autoantibodies, metabolites, and vitamin and mineral profiles [8].”
BackgroundZhou, M., Niu, B., Ma, J., Ge, Y., Han, Y., Wu, W., & Yue, C. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1535455 · Cited by 36
“Changes in the gut environment caused by gut microbiota affect the production of signaling substances (Srikantha and Mohajeri, 2019), thereby influencing mature brain function and the development of the central nervous system (CNS) both prenatally and postnatally (Dicks et al., 2021; Doifode et…”
Hajjeh, O., Rajab, I. M., Bdair, M., Saife, S., Zahran, A., Nazzal, I., AbuZahra, M. I., Jallad, H., Abukhalil, M. M., Hallak, M., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.015 · Cited by 25
A Healthy Gut for a Healthy Brain: Preclinical, Clinical and Regulatory Aspects
Petrella, C., Vecchioli, S. F., Cisale, G. Y., Strimpakos, G., Borg, J.-J., Ceccanti, M., Fiore, M., Monteleone, G., & Nisticò, R. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200730111528 · Cited by 27
Sex-related patterns of the gut-microbiota-brain axis in the neuropsychiatric conditions
Manosso, L. M., Lin, J. H. X., Carlessi, A. S., Recco, K. C. C., Quevedo, J., Gonçalves, C. L., & Réus, G. Z. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.04.001 · Cited by 24
Giulio, P. (2021) · Archives of Clinical Gastroenterology · doi:10.17352/2455-2283.000094 · Cited by 29
Recent Developments in Autism Genetic Research: A Scientometric Review from 2018 to 2022
Lim, M., Carollo, A., Dimitriou, D., & Esposito, G. (2022) · Genes · doi:10.3390/genes13091646 · Cited by 26
Romano, K., Shah, A., Schumacher, A., Zasowski, C., Zhang, T., Bradley-Ridout, G., Merriman, K., Parkinson, J., Szatmári, P., Campisi, S. C., et al. (2023) · Gut Microbiome · doi:10.1017/gmb.2023.16 · Cited by 27
“Additionally, SCFAs can reach the brain through the bloodstream, where they influence its development by modulating the production of neurotransmitters, for example, serotonin and dopamine (Srikantha and Mohajeri, 2019).”
BackgroundProgrammes to manage food selectivity in individuals with autism spectrum disorder
Breda, C., Santero, S., Conti, M. V., & Cena, H. (2024) · Nutrition Research Reviews · doi:10.1017/s0954422424000052 · Cited by 28
Xu, X., Cai, X., Meng, F., Song, T.-J., Wang, X., Wei, Y.-Z., Zhai, F.-J., Long, B., Wang, J., You, X., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.657105 · Cited by 26
An anxious relationship between Autism Spectrum Disorder and Gut Microbiota: A tangled chemistry?
Vellingiri, B., Aishwarya, S. Y., Jancy, S. B., Abhishek, G. S., Babu, H. W. S., Vijayakumar, P., Narayanasamy, A., Mariappan, S., Sangeetha, R., Gopalakrishnan, A. V., et al. (2022) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2022.03.003 · Cited by 33
Zeng, J., Liang, Y., Sun, R., Huang, S., Wang, Z., Xiao, L., Lu, J., Yu, H. Y., & Yao, P. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14766 · Cited by 24
Shen, L., Zhang, H., Jing, L., Gao, Y. L., Liu, X., Chen, M., Khan, N. U., Tang, X., Hong, Q., Feng, C., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02801-x · Cited by 24
“In general, the lack of vitamin B group in children with ASD may be caused by nutritional deficiency, poor absorption or alteration in gut microbiota [91, 96, 97], contributing to the pathogenesis of ASD.”
BackgroundJameson, C., Boulton, K., Silove, N., & Guastella, A. J. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02185-5 · Cited by 24
“Consequently, ASD is increasingly recognised as representing a broad range of neurodevelopmental disorders and subtypes that are associated with diverse physical and mental health comorbidities [3].”
BackgroundSeptyaningtrias, D. E., & Susilowati, R. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0092 · Cited by 24
The Microbiota/Microbiome and the Gut–Brain Axis: How Much Do They Matter in Psychiatry?
Marazziti, D., Buccianelli, B., Palermo, S., Parra, E., Arone, A., Beatino, M. F., Massa, L., Carpita, B., Barberi, F. M., Mucci, F., et al. (2021) · Life · doi:10.3390/life11080760 · Cited by 27
Liu, X., Cui, Y., Zhang, Y., Guo, X., Meng, Y., Wang, X., Qiu, B., Li, X., Liu, W., & Zhang, D. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113949 · Cited by 25
Xie, M., Gu, S., Hong, Y., Liu, Y., Rong, X., Lu, W., Liu, H., Algradi, A. M., Naseem, A., Shu, Z., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116392 · Cited by 24
Horecka-Lewitowicz, A., Lewitowicz, W., Kozieł, D., Lim, H., Lewitowicz, P., & Lewitowicz, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011283 · Cited by 25
A Computational Framework for Studying Gut-Brain Axis in Autism Spectrum Disorder
Mohammad, F. K., Palukuri, M. V., Shivakumar, S., Rengaswamy, R., & Sahoo, S. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.760753 · Cited by 25
“Furthermore, determination of toxin-induced neuronal abnormalities using just a bacterial community encompassed a gut model (Srikantha and Mohajeri, 2019).”
BackgroundDovgan, K. N., Gynegrowski, K., & Ferguson, B. J. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-022-05539-6 · Cited by 22
“Emerging evidence suggests that the microbiota-gut-brain axis plays an important role in the development and maintenance of GI problems in ASD (e.g., Srikantha & Mohajeri 2019; Kang et al., 2019).”
Wu, H., Chen, X., Zhang, S., & Li, J. (2022) · Nutrients · doi:10.3390/nu14204220 · Cited by 23
“decreased, compared with healthy controls [50].”
BackgroundSimone, R. D., Butera, A., Armida, M., Pèzzola, A., Boirivant, M., Potenza, R. L., & Ricceri, L. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.03.041 · Cited by 23
The gut-microbiota-brain axis in autism: what Drosophila models can offer?
Salim, S., Banu, A., Alwa, A., Gowda, S. B. M., & Mohammad, F. (2021) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-021-09378-x · Cited by 26
The gut microbiome and adult hippocampal neurogenesis: A new focal point for epilepsy?
Dohm-Hansen, S., Donoso, F., Lucassen, P. J., Clarke, G. A., & Nolan, Y. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105746 · Cited by 22
“, 2020), autism spectrum disorder (Srikantha and Mohajeri, 2019), Alzheimer’s disease (Kowalski and Mulak, 2019),”
BackgroundDubourdieu, P. M., & Guerendiain, M. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1202948 · Cited by 23
“Another study shows a positive correlation between Clostridium cluster XVIII and gastrointestinal symptoms such as constipation in autistic and neurotypical subjects (27, 31).”
BackgroundA Review on the Protective Effects of Probiotics against Alzheimer’s Disease
Mishra, V., Yadav, D., Solanki, K. S., Koul, B., & Song, M. (2023) · Biology · doi:10.3390/biology13010008 · Cited by 22
“According to Breit et al. and Srikantha and Mohajeri (2019), metabolic diseases are underpinned by malfunction of the gut–brain axis [30,31].”
BackgroundThe Gut-Brain Axis and Its Role in Depression
Nanthakumaran, S., Sridharan, S., Somagutta, M. K. R., Arnold, A. A., May, V., Pagad, S., & Malik, B. H. (2020) · Cureus · doi:10.7759/cureus.10280 · Cited by 23
“identified specific characteristics of the microbiota of ASD similarly to how the microbiota of MDD have been given a signature [26].”
Li, C., Liu, Y., Fang, H., Chen, Y., Weng, J., Zhai, M., Xiao, T., & Ke, X. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.493695 · Cited by 22
“Children with ASD are usually reported to have a “leaky gut” (32), altered gut permeability play a pathogenic role allowing the input of molecules, the gut microbiota can act through the permeability of gut barrier, undigested proteins are also absorbed by the body through an incomplete intestinal mucosal barrier and…”
BackgroundCould Candida Overgrowth Be Involved in the Pathophysiology of Autism?
Herman, A., & Herman, A. P. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11020442 · Cited by 25
“may increaseintestinal production of serotonin (5-hydroxytryptamine, 5-HT) at the expense of a lower synthesis in the brain (due to consumption of its precursor tryptophan), leading to hyperserotoninemia and behavioral outcomes in ASD children [15].”
BackgroundOrtí, J. E. D. L. R., Moneti, C., Serrano-Ballesteros, P., Castellano, G., Bayona-Babiloni, R., Carriquí-Suárez, A. B., Motos-Muñoz, M., Proaño, B., & Benlloch, M. (2023) · Nutrients · doi:10.3390/nu15143265 · Cited by 20
“are bacteria that exist in the human microbiota, and are responsible for degrading plant polysaccharides and participating in the synthesis of vitamin B1 [78].”
BackgroundDai, H., Jiang, Y., Liu, S., Li, D., & Zhang, X. (2024) · Food Research International · doi:10.1016/j.foodres.2024.114404 · Cited by 22
Gut microbiota on gender bias in autism spectrum disorder
Hao, X., Pan, J., Gao, X., Zhang, S., & Li, Y. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0042 · Cited by 20
Puetz, L., Delmont, T. O., Aizpurua, O., Guo, C., Zhang, G., Katajamaa, R., Jensen, P., & Gilbert, M. T. P. (2021) · Advanced Genetics · doi:10.1002/ggn2.202100018 · Cited by 21
Food Allergy-Induced Autism-Like Behavior is Associated with Gut Microbiota and Brain mTOR Signaling
Cao, L., He, H.-J., Zhao, Y., Wang, Z., Jia, X.-Y., Srivastava, K. D., Miao, M., & Li, X.-M. (2022) · Journal of Asthma and Allergy · doi:10.2147/jaa.s348609 · Cited by 20
Marano, G., Sfratta, G., Marzo, E. M., Cozzo, G., Abate, F., Traversi, G., Mazza, O., Capristo, E., Gaetani, E., & Mazza, M. (2025) · Children · doi:10.3390/children12111561 · Cited by 20
Gagliano, A., Murgia, F., Capodiferro, A. M., Tanca, M. G., Hendren, A. J., Falqui, S. G., Aresti, M., Comini, M., Carucci, S., Cocco, E. E., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216493 · Cited by 19
“The reduction in Gly bioavailability in ASD subjects is supposed to be related to malabsorption induced by gut dismicrobism and the inflammatory disruption of the intestinal barrier [26,27].”
BackgroundAltered Metabolic Characteristics in Plasma of Young Boys with Autism Spectrum Disorder
Wang, L., Zheng, R., Xu, Y., Zhou, Z., Guan, P., Wu, Y., Zhou, J. R., Cheng, Z., & Zhang, L. (2021) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-021-05364-3 · Cited by 19
“Accumulating evidence indicates that ASD is associated with imbalanced gut microbiota and its metabolites (Grimaldi et al., 2018; Hughes et al., 2018; Srikantha & Mohajeri, 2019).”
BackgroundJu, T., Zhang, Y., Liu, L., Zhao, X., Li, X., Liu, C., Sun, S., & Wu, L. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01419 · Cited by 18
“Consequently, the follow-up period for patients must be extended in future clinical studies (Yadegar et al., 2024).”
Emerging Role and Place of Probiotics in the Management of Pediatric Neurodevelopmental Disorders
Khanna, H. N., Roy, S., Shaikh, A., & Bandi, V. (2023) · Euroasian Journal of Hepato-Gastroenterology · doi:10.5005/jp-journals-10018-1384 · Cited by 19
Davies, M. R., Greenberg, Z., van Vuurden, D. G., Cross, C., Zannettino, A. C. W., Bardy, C., & Wardill, H. R. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.10.013 · Cited by 17
“…in other paediatric neurocognitive diseases, namely neurodevelopmental disorders (Fiorentino et al., 2016; Kochunov and Hong, 2014; Markka-nen et al., 2016; Panisi et al., 2021; Parenti et al., 2020; Srikantha and Mohajeri, 2019; Theoharides and Zhang, 2011; Valenti et al., 2014; Zamanpoor, 2020).”
BackgroundGalvis, C. A. N., Trejos-Gallego, D. M., Correa-Salazar, C., Triviño-Valencia, J., Buitrago, M. V., Ruiz-Pulecio, A. F., Méndez-Ramírez, L. F., Zabaleta, J., Meñaca-Puentes, M. A., Villa, C. A. R., et al. (2025) · Nutrients · doi:10.3390/nu17162664 · Cited by 18
“Thus, it is evident that non-pharmacological interventions, such as dietary strategies and probiotic supplements used in ASD interventions, become relevant in the face of growing evidence that nutritional and immunological factors can significantly influence the symptomatology of ASD [21].”
Risk of Parkinson disease associated with pesticide exposure and protection by probiotics
Rajawat, N. K., Bhardwaj, K., & Mathur, N. (2022) · Materials Today Proceedings · doi:10.1016/j.matpr.2022.12.153 · Cited by 21
Kang, X., Cheng, E., Guo, P., Xi, L., Xiang, C., Xu, S., Zhang, Y., Yang, Y., Zhang, J. J., & Long, H. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157009 · Cited by 19
Xiao, L., Wang, M., Zhang, W., Song, Y., Zeng, J., Li, H., Yu, H. Y., Li, L., Gao, P., & Yao, P. (2022) · BMC Neuroscience · doi:10.1186/s12868-022-00693-0 · Cited by 16
Butera, A., Simone, R. D., Potenza, R. L., Sanchez, M., Armida, M., Campanile, D., Carlo, N. D., Trenta, F., Boirivant, M., & Ricceri, L. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.09.024 · Cited by 16
Téglás, T., Marcos, A. C., Torices, S., & Toborek, M. J. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.175886 · Cited by 16
Rodrigues, E. L., Figueiredo, P. S., Marcelino, G., Guimarães, R. D. C. A., Pott, A., Santana, L. F., Hiane, P. A., do Nascimento, V. A., Bogo, D., & Freitas, K. D. C. (2023) · Nutrients · doi:10.3390/nu15071551 · Cited by 20
“Despite not being well established, research points to a possible link between ASD and the gut microbiota [45], which is correlated with the type of childbirth, breastfeeding time, gestational stress, use of antibiotics, and maternal diet [46].”
BackgroundBuitrago, M. V., Oliveira-Carvalho, R. D., Cardoso, V. N., Triviño-Valencia, J., Duque, L. M. S., Martínez-Díaz, V., Zabaleta, J., Galeano-Vanegas, N. F., & Galvis, C. A. N. (2025) · Pharmaceuticals · doi:10.3390/ph18091376 · Cited by 16
“These findings support the hypothesis that individuals with autism exhibit impaired intestinal barrier integrity and dysbiosis, which together disrupt the gut–brain axis; however, it remains unclear whether dysbiosis is a cause or consequence of ASD [27].”
Neurocognitive mechanisms underlying autism spectrum disorders: a literature review
Liu, S., Zeng, D., Yi, C.-A., & Zhu, M. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1633658 · Cited by 15
“The microbiota-gut-brain axis is one of the most potent mechanisms through which peripheral signals modulate central neurotransmitter activities (40) with neuropeptides being the most integrated elements of this intersystem communication (41).”
Zhao, T., Huang, C., Zhang, Y., Zhu, Y., Chen, X., Wang, T., Shao, J., Meng, X., Huang, Y., Wang, H., et al. (2024) · Advanced Science · doi:10.1002/advs.202306294 · Cited by 18
Zhu, G., Yan, L., Fang, L., Fan, C., Sun, H., Zhou, X., Zhang, Y., & Shi, Z. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1426911 · Cited by 16
“Both TNF-α and IFN-γ increase intestinal permeability by impairing tight junctions (Srikantha and Mohajeri, 2019).”
BackgroundMa, Y., Zhou, H., Li, C., Zou, X., Luo, X., Wu, L., Li, T., Chen, X., Mao, M., Huang, Y., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.624767 · Cited by 18
Yao, L., Fu, H., Bai, L., Deng, W., Xie, F., Li, Y., Zhang, R., Xu, X., Wang, T., Lai, S., et al. (2021) · Redox Report · doi:10.1080/13510002.2021.1959133 · Cited by 16
“Besides, certain bacteria-origin metabolites, including lipopolysaccharides and short chain fatty acids, were found in blood and urine of ASD children [66].”
BackgroundKarnachuk, O. V., Ikkert, O. P., Avakyan, M. R., Knyazev, Y. V., Volochaev, M. N., Zyusman, V. S., Panov, V. L., Kadnikov, V. V., Mardanov, A. V., & Ravin, N. V. (2021) · Microorganisms · doi:10.3390/microorganisms9122558 · Cited by 16
The Role of the Gut-Brain Axis in Diseases
Chen, J. W., Xu, Y., & Cao, P. (2025) · Physiology · doi:10.1152/physiol.00016.2025 · Cited by 18
Feng, P., Zhang, Y., Zhao, Y., Zhao, P., & Li, E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1341404 · Cited by 16
“The most common GI symptom in children with autism is constipation (47).”
BackgroundGhunaim, L., Agha, A. S. A. A., & Aburjai, T. A. (2024) · Jordan Journal of Pharmaceutical Sciences · doi:10.35516/jjps.v17i3.2410 · Cited by 14
“Metabolomics approaches have uncovered distinct metabolic byproducts, such as modified profiles of short-chain fatty acids (SCFAs), which can serve as potential biomarkers for gut dysbiosis or malabsorption in individuals with ASD [59, 60].”
BackgroundLiberto, D. D., D’Anneo, A., Carlisi, D., Emanuele, S., Blasio, A. D., Calvaruso, G., Giuliano, M., & Lauricella, M. (2020) · Brain Sciences · doi:10.3390/brainsci10070437 · Cited by 15
“This observation was also sustained by recent data, providing that the transplantation of gut microbiota from ASD patients in mice promotes the development of characteristic autistic behaviors [17], albeit differences between human and murine microbiota exist and such an aspect also has to be considered [18].”
ResultFujishiro, S., Tsuji, S., Akagawa, S., Akagawa, Y., Yamanouchi, S., Ishizaki, Y., Hashiyada, M., Akane, A., & Kaneko, K. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-022-05682-0 · Cited by 14
Righetto, I., Gasparotto, M., Casalino, L., Vacca, M., & Filippini, F. (2023) · Biomolecules · doi:10.3390/biom13010169 · Cited by 14
“Among external cues, the gut microbiota is the source of a number of bioactive metabolites [8] which shape the structure and function of brain regions involved in the control of emotions, cognition, and physical activity [9,10].”
BackgroundYu, R., Wu, Z., Wang, S., Zhang, M., Zhou, G., & Li, B. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104371 · Cited by 14
Saxami, G., Mitsou, E. K., Kerezoudi, E. N., Mavrouli, I., Vlassopoulou, M., Koutrotsios, G., Mountzouris, K. C., Zervakis, G. I., & Kyriacou, A. (2023) · Microorganisms · doi:10.3390/microorganisms11020414 · Cited by 15
“Butyrate modulates the biosynthesis of catecholamines and neurotransmitters in the central and autonomic nervous system, as well as promoting memory formation and neuronal plasticity through epigenetic modulation [69].”
Bhusri, B., Sutheeworapong, S., Kittichotirat, W., Kusonmano, K., Thammarongtham, C., Lertampaiporn, S., Prommeenate, P., Praphanphoj, V., Kittitharaphan, W., Dulsawat, S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-86740-2 · Cited by 16
Metal Dyshomeostasis as a Driver of Gut Pathology in Autism Spectrum Disorders
O'Grady, K., & Grabrucker, A. M. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70041 · Cited by 13
“…intricate bidirectional communication network between the microbiota, gut, and brain, known as the microbiota –gut –brain axis, and its involvement in ASD etiology might be key to understanding risk factors for ASD and developing prevention and treatment strategies (Srikantha and Mohajeri 2019).”
Hong, R., Hou, Y.-Y., Xu, X., Lang, J., Jin, Y., Zeng, X.-F., Zhang, X., Tian, G., & You, X. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.886196 · Cited by 17
Yu, R., Ahmed, T., Jiang, H., Zhou, G., Zhang, M., Lv, L., & Li, B. (2021) · Materials · doi:10.3390/ma14195488 · Cited by 14
“In the last decade, more and more children have been diagnosed with ASD, which affects approximately 8–12% of children school-aged children worldwide [1,5].”
BackgroundTu, G., Jiang, N., Chen, W., Liu, L., Hu, M., & Liao, B. (2024) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0058 · Cited by 14
Almheiri, R. T., Hajjar, B. M., Alkhaaldi, S. M. I., Rabeh, N., Aljoudi, S., Abd‐Elrahman, K. S., & Hamdan, H. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06201-2 · Cited by 14
“The increased gut permeability, in particular, can contribute to further gut dysbiosis, leading to lower beneficial Lactobacillus strains and possibly further pathogenesis [249].”
Yang, S., Wang, L., Liang, X., Pei, T., Zeng, Y., Xie, B., Wang, Y., Yang, M., Wei, D., & Cheng, W. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141715 · Cited by 15
Widjaja, F., & Rietjens, I. M. C. M. (2023) · Biomedicines · doi:10.3390/biomedicines11102658 · Cited by 13
Probiotics in autism spectrum disorder: Recent insights from animal models
Golbaghi, N., Naeimi, S., Darvishi, A., Najari, N., & Cussotto, S. (2024) · Autism · doi:10.1177/13623613241246911 · Cited by 12
“The depletion of the microbes in the murine intestinal tract could lead to organ dysfunction, particularly within the central nervous system (CNS), likely through the so-called “gut-brain axis” (Srikantha & Mohajeri, 2019).”
Plaza‐Díaz, J., Radar, A. M., Baig, A. T., Leyba, M. F., Costabel, M. M., Zavala-Crichton, J. P., Sanchez‐Martinez, J., MacKenzie, A., & Solis‐Urra, P. (2022) · Children · doi:10.3390/children9121834 · Cited by 14
Kamalmaz, N., Bacha, A. G. B., Alonazi, M. A., Albasher, G. I., Khayyat, A. I. A., & El-Ansary, A. K. (2023) · PeerJ · doi:10.7717/peerj.15488 · Cited by 11
Metadata
- Authors
- Srikantha, P., & Mohajeri, M. H.
- Affiliations
- University of Zurich (CH)
- Corresponding author
- Mohajeri, M. Hasan
- ORCID
- Mohajeri, M. Hasan
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-04-29
- Volume
- 20
- Issue
- 9
- Pages
- 2115
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6539237
- OpenAlex
- W2943088522
- Cited by
- 400
- References
- 137
- Citations by year
- 2026: 32 · 2025: 68 · 2024: 60 · 2023: 64 · 2022: 67 · 2021: 56 · 2020: 42 · 2019: 11
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- autism spectrum disorder, gut microbiota, microbiota-gut-brain axis, dysbiosis, gastrointestinal symptoms, bacterial metabolites, short-chain fatty acids, indole, lipopolysaccharide, leaky gut, blood-brain barrier, mitochondrial dysfunction, oxidative stress, probiotics, phenylalanine metabolism, biomarkers
- MeSH terms
- Autism Spectrum Disorder, Gastrointestinal Microbiome, Animals, Brain, Child, Humans, Intestinal Mucosa, Intestines, Mitochondria, Risk Factors, Comorbidity, Probiotics, Biodiversity, Metabolic Networks and Pathways, Metabolomics, Prebiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.